Clinical Trial Update: Tolerability of Lopinavir Versus Dolutegravir for Children and Adolescents Living With HIV

View source ↗

Summary

This clinical trial update compares tolerability of lopinavir versus dolutegravir in children and adolescents living with HIV. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)
• Tivicay (dolutegravir)

Snippet

Sponsor: Swiss Tropical & Public Health Institute | Conditions: HIV | Status: COMPLETED